fact-sheet
In Vitro ADME Services
Frontage Global Drug Discovery Services (GDDS) offers a full spectrum of in vitro ADME assays for small molecule drug discovery and preclinical development. Our strong focus on lab operations, automation, and project management enables efficient delivery and unparalleled quality. We believe in a customer-centric approach providing real-time communication and reliable consultations to Sponsors.
Resources to Consider
fact-sheet
In Vitro Cardiac Safety Evaluation
The FDA and the ICH S7B provide guidelines for assessing cardiac safety. In Vitro Assays a...
poster
IN Vitro Assessment of the inhibition of Human Organic Anion...
The present study was aimed to validate this alternate approach to assess inhibition of or...
podcast
In Vitro BE Study in ANDA Drug Product Development
In this podcast, we talk about an in vitro bioequivalence (BE) Study in ANDA drug developm...
poster
Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption
EMLA Cream (lidocaine 2.5% and prilocaine 2.5%) is an emulsion in which the oil phase is a...
poster
An Unexpected Major Circulating Metabolite M219 Detected in...
At Frontage Laboratories, a systematic method development approach has been established by...
![Genotoxic Potential of Benzo[b]Fluoranthene (B[b]F):A Probable Human Carcinogen](https://www.frontagelab.com/wp-content/uploads/2025/09/BBF-poster-335x180.png)
poster
Genotoxic Potential of Benzo[b]Fluoranthene (B[b]F):A Probable Human...
Explore our EMGS 2025 poster on the Genotoxic Potential of Benzo[b]fluoranthene (B[b]F). T...
Duplex Sequencing: A Powerful Tool for In Vivo Gene Mutation
Discover our EMGS 2025 poster showcasing how Duplex Sequencing (ecNGS) reveals the genotox...
poster
STP 2025: Organ Weight Data Interpretation in Toxicology Studies
Organ weight analysis is a key endpoint in toxicology studies, but interpretation can be c...
